Landau-Kleffner Syndrome Medication Savings with TheDrugClub
Discount pricing may be available. Current formulary eligibility is being verified; a condition association does not establish FREE coverage.
- Join TheDrugClub as a member
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available discount pricing
About Landau-Kleffner Syndrome
Landau-Kleffner Syndrome (LKS) is a rare neurological disorder primarily affecting children, characterized by the sudden or gradual loss of language skills and recurrent seizures. This challenging condition requires ongoing medical care and often costly medications. TheDrugClub is dedicated to easing the financial burden for families, helping members afford the vital prescriptions needed to manage LKS symptoms and support their child's well-being.
Landau-Kleffner Syndrome (LKS) is a rare and complex neurological disorder that typically emerges in children between the ages of three and seven. It's often described as an acquired epileptic aphasia because its hallmarks are the sudden or gradual loss of a child's ability to understand (receptive aphasia) and express (expressive aphasia) spoken language, alongside abnormal electrical activity in the brain, often manifesting as seizures. These seizures can range from obvious convulsive episodes to more subtle, non-convulsive seizures that might only be detectable through an electroencephalogram (EEG).
The exact cause of LKS is not fully understood, but it's believed to involve abnormal electrical discharges in the language-processing areas of the brain. The impact on a child's development can be significant, affecting not only communication but also learning, behavior, and social interactions. Early diagnosis, often involving detailed neurological evaluations and continuous EEG monitoring, is crucial for timely intervention.
Treatment for LKS focuses on controlling seizures and abnormal brain activity, as well as supporting language development. Common medications include anticonvulsants such as valproate, levetiracetam, or clonazepam, which help to stabilize brain activity and reduce seizure frequency. Corticosteroids like prednisone are also frequently prescribed, especially in severe cases, to help suppress brain inflammation and improve language outcomes. In some instances, immunoglobulin therapy (IVIG) may be considered. Beyond medication, intensive speech and language therapy is a cornerstone of treatment, often complemented by occupational therapy and behavioral support to address developmental and emotional challenges.
Managing a condition like LKS can involve a significant financial strain due to the need for ongoing prescriptions. That's where TheDrugClub steps in. For a low monthly membership fee – with a Drug Club membership – you gain access to significantly
The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.